...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!
Message: Re: Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment
"I doubt Eversana can announce anything until this news release was first made public. But I assume they will be a fast follower now."
I suspect that Eversana will make "Apabetalone/COVID-19" public once they know that it works and not before. They will only back up a successful study.